Drug & medication recalls Moderate risk

Time-Cap Labs recalled over manufacturing violations

Recall date
October 2, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Marksans Pharma Limited recalls Time-Cap Labs, Inc. Metformin Hydrochloride Extended Release Tablets USP 750 mg, 100 count bottles, Rx Only Manufacture…
Recall number
D-0062-2021
FDA classification
Class II
Brand / firm
Marksans Pharma Limited
Sold / distributed
Nationwide

Why it was recalled

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Time-Cap Labs, Inc. Metformin Hydrochloride Extended Release Tablets USP 750 mg, 100 count bottles, Rx Only Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83, Verna Indl. Estate. Verna Goa-403 722 India NDC 49483-624-01

Get recall alerts

Free email alert whenever Marksans Pharma Limited has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Marksans Pharma Limited